2,5-Pyrazinediamine
97%
- Product Code: 51464
CAS:
768386-37-4
| Molecular Weight: | 110.1200 g./mol | Molecular Formula: | C₄H₆N₄ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09835012 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature |
Product Description:
Used primarily in the synthesis of pharmaceutical compounds, 2,5-Pyrazinediamine serves as a key intermediate in the production of drugs targeting tuberculosis and other bacterial infections. Its role in the development of antitubercular agents is particularly significant, as it contributes to the creation of molecules that inhibit the growth of Mycobacterium tuberculosis. Additionally, this compound finds application in organic synthesis, where it is utilized to construct complex heterocyclic structures that are essential in various medicinal chemistry projects. Its reactivity and ability to form stable bonds make it a valuable component in the design of novel therapeutic agents.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Solid |
| PURITY | 94.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.050 | 10-20 days | $78.07 |
+
-
|
| 0.200 | 10-20 days | $206.81 |
+
-
|
| 1.000 | 10-20 days | $521.60 |
+
-
|
2,5-Pyrazinediamine
Used primarily in the synthesis of pharmaceutical compounds, 2,5-Pyrazinediamine serves as a key intermediate in the production of drugs targeting tuberculosis and other bacterial infections. Its role in the development of antitubercular agents is particularly significant, as it contributes to the creation of molecules that inhibit the growth of Mycobacterium tuberculosis. Additionally, this compound finds application in organic synthesis, where it is utilized to construct complex heterocyclic structures that are essential in various medicinal chemistry projects. Its reactivity and ability to form stable bonds make it a valuable component in the design of novel therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :